Hydralazine Hydrochloride Injection (Hydrataj) – PAN India Manufacturer & Global Supplier
Taj Pharmaceuticals Ltd, a WHO-GMP and ISO-certified pharmaceutical leader headquartered in Mumbai with state-of-the-art manufacturing facilities in Vapi, Gujarat, is one of India’s most trusted names in the production and supply of Hydralazine Hydrochloride Injection 20mg/ml (Hydrataj). We specialize in delivering high-quality, effective, and globally compliant formulations to meet domestic and international healthcare demands.
About Hydralazine Hydrochloride Injection
Hydralazine Hydrochloride Injection is a potent vasodilator used to treat severe hypertension, hypertensive emergencies, and acute heart failure when rapid blood pressure reduction is required, and oral administration is not feasible. The medicine works by relaxing and widening small blood vessels, improving blood flow, and lowering vascular resistance.
- Strength: 20mg/ml
- Dosage Form: Injection (IV/IM)
- Onset of Action: 10–80 minutes
- Duration: 2–6 hours
Why Choose Taj Pharma as Your Hydralazine Hydrochloride Injection Manufacturer?
WHO-GMP Certified Facilities
We manufacture Hydralazine Hydrochloride Injection in state-of-the-art, WHO-GMP certified plants with strict adherence to international pharmacopoeial standards (IP/BP/USP).
Unmatched Quality Control
Every batch undergoes rigorous analytical testing, stability studies, and validation procedures to ensure efficacy, purity, and safety.
Global Export Expertise
Our supply network spans Africa, the Middle East, LATAM, CIS countries, and Asia, with full regulatory support including COA, COPP, and stability data.
Therapeutic Indications
Hydralazine Hydrochloride Injection is indicated for:
- Severe or life-threatening hypertension
- Hypertensive crisis in hospital settings
- Pregnancy-induced hypertension (PIH) when alternatives are unsuitable
- Adjunct therapy in acute heart failure
Dosage & Administration
- Route: Intravenous (IV) or Intramuscular (IM)
- Adult Dosage: Adjusted as per patient’s condition and response
- Special Populations: Lower doses recommended for patients with renal impairment
- Medical Supervision: Must only be administered by qualified healthcare professionals
Precautions & Safety Information
Pregnancy & Breastfeeding
- Pregnancy: Use with caution; prescribed only when benefits outweigh potential risks.
- Breastfeeding: Considered safe; minimal drug transfer into breast milk.
Alcohol Interaction
Avoid alcohol during treatment as it may enhance hypotensive effects.
Driving
May cause dizziness or headaches; avoid driving or operating heavy machinery until you know how the medicine affects you.
Possible Side Effects
Common side effects include:
- Headache
- Nausea & vomiting
- Loss of appetite
- Diarrhea
- Increased heart rate
- Dizziness
- Flushing
Seek immediate medical attention if side effects persist or worsen.
Storage & Handling
- Store below 25°C, away from direct sunlight
- Protect from freezing
- Use immediately after opening
- Do not mix with other solutions
- Discard discolored or contaminated solutions
Technical Specifications
| Parameter | Details |
|---|---|
| Generic Name | Hydralazine Hydrochloride Injection |
| Brand Name | Hydrataj |
| Strength | 20mg/ml |
| Dosage Form | Injection |
| Route | IV/IM |
| Packing | 10 x 2ml ampoules |
| Manufacturer | Taj Pharmaceuticals Ltd., Vapi, Gujarat, India |
| Compliance | WHO-GMP, ISO, Schedule M |
| Export Markets | Africa, Middle East, LATAM, Asia |
PCD Pharma Franchise & Third-Party Manufacturing
We offer exclusive PCD Pharma Franchise opportunities and third-party manufacturing services for Hydralazine Hydrochloride Injection. Our clients benefit from:
- Competitive pricing
- Attractive product packaging
- Regulatory and marketing support
- Flexible MOQs for start-ups and established distributors
Global Export Markets
Our products are trusted by government health programs, hospitals, NGOs, and private institutions worldwide. Export regions include:
- Africa: Nigeria, Kenya, Ghana, South Africa, Uganda
- Middle East: UAE, Saudi Arabia, Oman, Yemen
- LATAM: Brazil, Peru, Mexico, Colombia
- Asia: Vietnam, Philippines, Bangladesh
Why Hydralazine Hydrochloride Injection is Vital in Emergency Care
Hypertension is a leading cause of stroke, heart attack, kidney damage, and cardiovascular mortality. In emergency situations, Hydralazine Hydrochloride Injection provides a rapid, life-saving intervention to stabilize blood pressure and prevent organ damage.
Ordering Information
For bulk procurement, hospital tenders, or export partnerships:
📧 Email: info@tajpharma.com
🌍 Website: www.tajpharma.com
📞 Call/WhatsApp: +91 84484 44095
📠 Fax: +91 – 22 – 2634 1274
Taj Pharma’s Hydralazine Hydrochloride Injection (Hydrataj) is backed by pharmaceutical expertise, stringent quality standards, and global trust. Whether for local supply or international distribution, we deliver purity, safety, and therapeutic efficacy in every ampoule.








